References
- Cheson B.D. The myelodysplastic syndromes: current approaches to therapy. Ann. Int. Med. 1990; 112: 932–941
- Anderson J.E., Appelbaum F.R., Fisher L.D., et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677–681
- Ratanatharalhom V., Karanes C., Uberti J., et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood 1993; 81: 2194–2199
- Nevill T.J., Shepherd J.D., Reece D.E., et al. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplantation 1992; 10: 445–450
- Sutton L., Leblond V., Le Maignan C., et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplantation 1991; 7: 39, (suppl 2)
- De Witte T., Zwaan F., Hermans J., et al. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br. J. Haematol. 1990; 14: 151–155
- Longmore G., Guinan E.C., Weinstein H.J., et al. Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. J. Clin. Oncol. 1990; 8: 1707–1714
- O'Donnell M.R., Nademanee A.P., Snyder D.S., et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J. Clin. Oncol. 1987; 5: 1822–1826
- Fisher L.D., Van Belle G. Biostatistics: Methodology for the Health Sciences. John Wiley and Sons, New York, N. Y. 1993, chapter 16
- Clift R.A., Appelbaum F.R., Thomas E.D. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954–1956
- Goldman J.M., Szydlo R., Horowitz M.M., et al. Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993; 82: 2235–2238
- Anderson J.E., Appelbaum F.R., Storb R., Anasetti C. Busulfan and cyclophosphamide with or without total body irradiation as preparative regimens for patients undergoing allogeneic bone marrow transplantation for myelodysplastic syndrome. Blood 1993; 82(suppl 1)377a, (abstract #1494)